Results 241 to 250 of about 12,161,547 (411)

Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys

World Psychiatry, 2017
L. Degenhardt, M. Glantz, S. Evans-Lacko, E. Sadikova, N. Sampson, G. Thornicroft, S. Aguilar-Gaxiola, A. Al-Hamzawi, J. Alonso, Laura Helena Andrade, R. Bruffaerts, B. Bunting, E. Bromet, José Miguel Caldas de Almeida, G. de Girolamo, S. Florescu, O. Gureje, Josep María Haro, Yueqin Huang, A. Karam, E. Karam, A. Kiejna, Sing Lee, J. Lépine, D. Levinson, María Elena Medina‐Mora, Yosikazu Nakamura, F. Navarro-Mateu, B. Pennell, J. Posada-Villa, K. Scott, D. Stein, M. ten Have, Y. Torres, Z. Zarkov, S. Chatterji, R. Kessler   +36 more
semanticscholar   +1 more source

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

Molecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma, Sophia M. Orbach, Kate V. Griffin, Kathryn Kang, Yining Zhang, Rebecca S. Pereles, Ian A. Schrack, Guillermo Escalona, Jacqueline S. Jeruss, Lonnie D. Shea   +9 more
wiley   +1 more source

Assessing the efficiency of HIV prevention interventions in Kenya – the ORPHEA Project

Annals of Global Health, 2015
R. Wamai, R. Buzdugan, O. Galarraga, C. Chaumont, S. Sosa-Rubi, S. Bautista, J. Wang'ombe, I. Ochoa Moreno, H. Nyakundi, M. Mugo, A. Kwan, A. Sassi, G. Bollinger   +12 more
doaj   +1 more source

Pathway to effective treatment for common mental and substance use disorders in the World Mental Health Surveys: Perceived need for treatment. [PDF]

Int J Ment Health Syst
Harris MG, Kazdin AE, Hwang I, Manoukian SM, Sampson NA, Stein DJ, Viana MC, Vigo DV, Alonso J, Andrade LH, Bruffaerts R, Bunting B, Caldas-de-Almeida JM, Chardoul S, de Girolamo G, Gureje O, Haro JM, Karam EG, Kovess-Masfety V, Medina-Mora ME, Navarro-Mateu F, Nishi D, Posada-Villa J, Rapsey C, Stagnaro JC, Ten Have M, Wciórka J, Zarkov Z, Kessler RC, World Mental Health Survey collaborators.   +29 more
europepmc   +1 more source

Surveys, Symposia, and Transactions: Child Care in Health and Disease [PDF]

, 1969
C. O. Carter
openalex   +1 more source

Detecting homologous recombination deficiency for breast cancer through integrative analysis of genomic data

Molecular Oncology, EarlyView.
This study develops a semi‐supervised classifier integrating multi‐genomic data (1404 training/5893 validation samples) to improve homologous recombination deficiency (HRD) detection in breast cancer. Our method demonstrates prognostic value and predicts chemotherapy/PARP inhibitor sensitivity in HRD+ tumours.
Rong Zhu, Katherine Eason, Suet‐Feung Chin, Paul A. W. Edwards, Raquel Manzano Garcia, Richard Moulange, Jia Wern Pan, Soo Hwang Teo, Sach Mukherjee, Maurizio Callari, Carlos Caldas, Stephen‐John Sammut, Oscar M. Rueda   +12 more
wiley   +1 more source

The Bambuí health and ageing study (BHAS): methodological approach and preliminary results of a population-based cohort study of the elderly in Brazil

Revista de Saúde Pública
OBJECTIVE: A cohort study has been designed to identify predictors of adverse health events in the elderly. The methodology of the study and preliminary descriptive results are presented.
Maria Fernanda F Lima e Costa, Elizabeth Uchoa, Henrique L Guerra, Josélia OA Firmo, Pedro G Vidigal, Sandhi M Barreto   +5 more
doaj  

Association between antenatal care visits and under-five mortality: An Analysis of the Pakistan demographic and health surveys. [PDF]

PLoS One
Nawaz R, Gong S, Zhao Y, Khalid N, Zhou Z, Waseem M.   +5 more
europepmc   +1 more source

Evaluation of KRAS and NRAS mutations in metastatic colorectal cancer: an 8‐year study of 10 754 patients in Turkey

Molecular Oncology, EarlyView.
This nationwide study evaluated KRAS and NRAS mutations in 10 754 Turkish patients with metastatic colorectal cancer. The results revealed a mutation frequency of 51.1%, with 46.6% having KRAS mutations, 4.5% having NRAS mutations, and 48.5% being wild‐type for both.
Gozde Kavgaci, Izzet Akiva, Yavuz Hakan Ozon, Hakan Berkil, Huseyin Karadayi, Omer Dizdar, Suayib Yalcin   +6 more
wiley   +1 more source

Poverty, cash transfers, and risk behaviours

The Lancet Global Health, 2013
Stefano M Bertozzi, Juan-Pablo Gutiérrez   +1 more
doaj   +1 more source